The research of Alexander Ljubimov, PhD, focuses on gene therapy for diabetic corneal stem cells, generation of corneal epithelium from iPSC for limbal stem cell deficiency therapy, inhibition of protein kinase CK2 to block pathological retinal angiogenesis and tumor growth, miRNA in normal and diabetic cornea, and targeted nanodrugs for cancer.

View NIH Biographical Sketch as a PDF

• Master's: Lomonosov Moscow State University, 1974
• Doctorate: N.N. Blokhin Russian Cancer Research Center, 1979
• Post Doctorate: International Agency for Research on Cancer, 1983

View CV as a PDF

• Cancer Institute (Samuel Oschin Comprehensive Cancer Institute)
• Department of Surgery
• Biomedical Sciences
• Cancer
• Neurosurgery
• Regenerative Medicine Institute (Board of Governors Regenerative Medicine Institute)

• Editorial Board Member: PLoS One, Current
• American Diabetes Association, Current
• Royal Society of Medicine, London, Current
• International Society for Eye Research, Current
• Executive Editor: Experimental Eye Research, Current

Click here for a list of peer-reviewed publications.

• Patil R, Ljubimov AV, Gangalum PR, Ding H, Portilla-Arias J, Wagner S, Inoue S, Konda B, Rekechenetskiy A, Chesnokova A, et al. MRI virtual biopsy and treatment of brain metastatic tumors with targeted nanobioconjugates: nanoclinic in the brain. ACS Nano. 2015;9(5):5594-5608.
• Sareen D, Saghizadeh M, Ornelas L, Winkler MA, Narwani K, Sahabian A, Funari VA, Tang J, Spurka L, Punj V, Maguen E, Rabinowitz YS, Svendsen CN, Ljubimov AV. Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium. Stem Cells Transl Med. 2014;3(9):1002-1012.
• Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 2011;54 Suppl 1:S204-217.